Sana Biotechnology, Inc. Temporary Equity, Liquidation Preference
Sana Biotechnology, Inc. (SANA) had Temporary Equity, Liquidation Preference of $0 as of 2021-06-30, per its 10-Q filed 2021-08-04.
Discontinued › Balance Sheet › Temporary Equity › Temporary Equity, Other Disclosure
us-gaap:TemporaryEquityLiquidationPreference · last filed 2021-08-04
- 2021-06-30: Temporary Equity, Liquidation Preference $0.00.
- 2021-03-31: Temporary Equity, Liquidation Preference $0.00.
- 2020-12-31: Temporary Equity, Liquidation Preference $926.67M.
| Period end | Temporary Equity, Liquidation Preference |
|---|---|
| 2021-06-30 | $0.00 10-Q · filed 2021-08-04 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-05 |
| 2020-12-31 | $926.67M 10-Q · filed 2021-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |